Corrigendum to "Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2"

Evid Based Complement Alternat Med. 2019 Jan 10:2019:9791436. doi: 10.1155/2019/9791436. eCollection 2019.

Authors

Yong Wang¹, Chun Li¹, Yulin Ouyang¹, Junda Yu¹, Shuzhen Guo¹, Zhongyang Liu², Dong Li², Jing Han¹, Wei Wang¹

Affiliations

¹ Beijing University of Chinese Medicine, Bei San Huan Dong Lu 11, Chao Yang District, Beijing 100029, China.
² State Key Laboratory of Proteomics, Beijing Proteome Research Center, Institute of Radiation Medicine, Beijing 100850, China.

Abstract

[This corrects the article DOI: 10.1155/2012/978127.].

Publication types

Published Erratum